Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-C SF activated STAT5 signalling pathway

Turleb, R. K.; Fiévez, L.; Saridersen, C. F.; Dogné, S.; Kirschvink, N.; Lekeux, P.; Bureau, F.
September 2001
Thorax;Sep2001, Vol. 56 Issue 9, p696
Academic Journal
Background--As granulocyte/macrophage colony stimulating factor (GM-CSF) mediated delay of granulocyte apoptosis contributes to the accumulation of inflammatory cells at the site of inflammation in many diseases, we sought to determine whether asthma is also associated with a GM-CSF dependent increase in lung granulocyte survival. Moreover, because GM-CSF mediates its effects through activation of signal transducer and activator of transcription 5 (STAT5), we also investigated the potential role of STAT5 in allergic inflammation. Methods-Blood granulocytes were recovered from six healthy and six heaves affected horses, a model of asthma. Lung granulocytes were obtained by bronchoalveolar lavage (BAL) from the same horses. Granulocytes were cultured in the presence or absence of anti-GM-CSF receptor antibodies for different times and apoptosis was determined using the Annexin-V/propidium iodide detection method. Nuclear protein extracts from cultured granulocytes were analyzed for STAT5 binding activity by electrophoretic mobility shift assay. Results-BAL fluid granulocytes from heaves affected horses demonstrated a significant delay in apoptosis compared with blood granulocytes from the same horses and blood and BAL fluid granulocytes from healthy horses. Conversely, the rate of apoptosis in blood granulocytes from healthy and heaves affected horses was comparable. The enhanced survival of BAL fluid granulocytes from affected horses was suppressed in the presence of antibodies directed against GM-CSF receptors. Increased levels of active STATS were found in BAL fluid granulocytes from heaves affected horses and were markedly reduced after treatment with anti-GM-CSF receptor antibodies. Conclusions-These data indicate that granulocyte survival is enhanced in the lung of heaves affected horses and suggest a role for a GM-CSF activated STAT5 pathway in delaying apoptosis of lung granulocytes in this model of asthma.


Related Articles

  • Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis. Latzin, P.; Tredano, M.; Wüst, Y.; de Blic, J.; Nicolai, T.; Bewig, B.; Stanzel, F.; Köhler, D.; Bohuau, M.; Griese, M. // Thorax;Jan2005, Vol. 60 Issue 1, p39 

    Background: Auto-antibodies against granulocyte-macrophage colony stimulating factor (GM-CSF) may be central to the pathogenesis of adult sporadic pulmonary alveolar proteinosis (PAP). The role of anti- GM-CSF auto-antibodies in paediatric farms of PAP is as yet unclear. Methods: Anti-GM-CSF...

  • Diagnosis of Chronic Obstructive Pulmonary Disease. Stephens, Mark B.; Yew, Kenneth S. // American Family Physician;7/1/2008, Vol. 78 Issue 1, p87 

    Chronic obstructive pulmonary disease affects more than 26 million adults in the United States. Family physicians provide care for most of these patients. Cigarette smoking is the leading risk factor for chronic obstructive pulmonary disease, although other risk factors, including occupational...

  • Journalwatch@pcrj.  // Primary Care Respiratory Journal;Sep2012, Vol. 21 Issue 3, p349 

    The article reviews several articles including "Reduced Lung Function in Neonatate is Associated With an Increased Risk of Asthma at Age 7," by Bisgaard et al. published in the "American Journal of Respiratory Care Medicine", "Asthma and Rhinitis: Further Evidence for one Airway Hypothesis," by...

  • Non-Invasive Assessment of Airway Inflammation in Asthma: An Overview. Shaw, D. E.; Pavord, I. D. // Current Respiratory Medicine Reviews;2006, Vol. 2 Issue 2, p189 

    The goals of asthma management are the accurate diagnosis and effective control of symptoms, prevention of exacerbations and the achievement and preservation of best pulmonary function. Despite improvements in asthma care patients are still misdiagnosed or undertreated. The reason for this is...

  • Safety and tolerability of three consecutive bronchoscopies after allergen challenge in volunteers with mild asthma. Kariyawasam, H. H.; Aizen, M.; Kay, A. Borry; Robinson, D. S. // Thorax;Jun2007, Vol. 62 Issue 6, p557 

    The article discusses a study on the safety and tolerability of three consecutive bronchoscopies after allergen challenge in volunteers with mild asthma. There was no significant correlation between the change in oxygen saturation and the volume of bronchoalveolar lavage recovered. All the...

  • Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene. Xiaoyuan Kong; Weidong Zhang; Lockey, Richard F.; Auais, Alexander; Piedimonte, Giovanni; Mohapatra, Shyam S. // Genetic Vaccines & Therapy;2007, Vol. 5, p4 

    Background: Respiratory syncytial virus (RSV) causes severe bronchiolitis and is a risk factor for asthma. Since there is no commercially available vaccine against RSV, a short interfering RNA against the RSV-NS1gene (siNS1) was developed and its potential for decreasing RSV infection and...

  • Breathing easier. King, Gregory; Pare, Peter D. // CMAJ: Canadian Medical Association Journal;12/15/97, Vol. 157 Issue 12, p1677 

    Discusses two areas of respiratory medicine in which advances were made in 1997. Chronic obstructive pulmonary disease; Prevalence of smoking; Prevalence and severity of asthma; Identifying the genetic roots of asthma; Developments in asthma pharmacotherapy.

  • Evolving concepts on the value of adenosine hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Polosó, R.; Rorke, S.; Holgate, S. T. // Thorax;Jul2002, Vol. 57 Issue 7, p649 

    The article examines the mechanism by which adenosine mediates bronchoconstriction in asthma and chronic obstructive pulmonary disease (COPD). The evidence in favour of the hypothesis that airway response to adenosine may better discriminate the inflammatory and immunological processes in asthma...

  • Increase in prevalence of physician-diagnosed asthma in Helsinki during the Finnish Asthma Programme: improved recognition of asthma in primary care? A cross-sectional cohort study. Kainu, Annette; Pallasaho, Paula; Piirilä, Päivi; Lindqvist, Ari; Sovijärvi, Anssi; Pietinalho, Anne // Primary Care Respiratory Journal;Mar2013, Vol. 22 Issue 1, p64 

    Background: The continuing rise in asthma prevalence has been questioned, with recent reports suggesting a plateau. Aims: To assess a 10-year trend in the age-adjusted prevalence of physician-diagnosed asthma, respiratory and allergic symptoms, and use of asthma medication in the adult...


Read the Article


Sign out of this library

Other Topics